Tenax Therapeutics (TENX) Current Leases (2020 - 2021)

Tenax Therapeutics (TENX) posted quarterly Current Leases of $101461.0 for Q2 2021, up 230.03% on a QoQ basis from $30743.0 in Q1 2021.

Tenax Therapeutics (TENX) Current Leases (2020 - 2021) Analysis & Trends

Tenax Therapeutics has reported Current Leases for 2 years, with the latest figure at $101461.0 in Q2 2021.

Current Leases for Q2 2021 came in at $101461.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $101461.0 (changed N/A YoY), and the FY2020 annual result was $60379.0, changed N/A from the prior year.
Current Leases rose to $101461.0 in Q2 2021, from $30743.0 in the prior quarter.
Over five years, Current Leases peaked at $101461.0 in Q2 2021 and troughed at $30743.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	720.00 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	21.95 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	45.93 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	6.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Tenax Therapeutics	78.47 Mn	78.47 Mn	-	-

Download Data